On December 3, 221, the National Medical Insurance Bureau published the National Drug List of Basic Medical Insurance, Work Injury Insurance and Maternity Insurance (221). China's first 1? Haibomaibu tablets, a cholesterol absorption inhibitor with independent intellectual property rights, have been included in the national medical insurance drug list. Haibo Maibu tablets entered the national medical insurance, marking a new step for China's independent innovative drugs.